Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

11C-Labeled isoniazid.

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Aug 2 [updated 2010 Oct 1].

2.

11C-Labeled rifampicin.

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Aug 2 [updated 2010 Sep 1].

3.

11C-Labeled pyrazinamide.

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Aug 2 [updated 2010 Oct 1].

4.

Treatment of extrapulmonary tuberculosis.

Dutt AK, Stead WW.

Semin Respir Infect. 1989 Sep;4(3):225-31. Review.

PMID:
2688005
5.

Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.

Sharma SK, Sharma A, Kadhiravan T, Tharyan P.

Cochrane Database Syst Rev. 2013 Jul 5;(7):CD007545. doi: 10.1002/14651858.CD007545.pub2. Review.

PMID:
23828580
6.

Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.

Verbeeck RK, Günther G, Kibuule D, Hunter C, Rennie TW.

Eur J Clin Pharmacol. 2016 Aug;72(8):905-16. doi: 10.1007/s00228-016-2083-4. Epub 2016 Jun 15. Review.

PMID:
27305904
7.

[Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].

Shishido Y, Nagayama N, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Komatsu H, Yotsumoto H.

Kekkaku. 2003 Nov;78(11):683-9. Review. Japanese.

PMID:
14672045
8.

Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities.

Vilchèze C, Jacobs WR Jr.

Microbiol Spectr. 2014 Aug;2(4):MGM2-0014-2013. doi: 10.1128/microbiolspec.MGM2-0014-2013. Review.

PMID:
26104204
9.

[Molecular mechanisms of multidrug resistance in Mycobacterium tuberculosis].

Taniguchi H.

J UOEH. 2000 Sep 1;22(3):269-82. Review. Japanese.

PMID:
11019393
10.

Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Sullins AK, Abdel-Rahman SM.

Paediatr Drugs. 2013 Apr;15(2):93-117. doi: 10.1007/s40272-013-0017-5. Review.

PMID:
23529866
11.

Potential Use of Calpain Inhibitors as Brain Injury Therapy.

Cagmat EB, Guingab-Cagmat JD, Vakulenko AV, Hayes RL, Anagli J.

In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 40.

12.

Slow-onset inhibition of 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis by an inorganic complex.

Oliveira JS, de Sousa EH, de Souza ON, Moreira IS, Santos DS, Basso LA.

Curr Pharm Des. 2006;12(19):2409-24. Review.

PMID:
16842188
13.

Recent Advances and Structural Features of Enoyl-ACP Reductase Inhibitors of Mycobacterium tuberculosis.

Inturi B, Pujar GV, Purohit MN.

Arch Pharm (Weinheim). 2016 Nov;349(11):817-826. doi: 10.1002/ardp.201600186. Epub 2016 Oct 24. Review.

PMID:
27775177
14.

Fighting tuberculosis by drugs targeting nonreplicating Mycobacterium tuberculosis bacilli.

Iacobino A, Piccaro G, Giannoni F, Mustazzolu A, Fattorini L.

Int J Mycobacteriol. 2017 Jul-Sep;6(3):213-221. doi: 10.4103/ijmy.ijmy_85_17. Review.

15.

11C-Labeled 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2009 Dec 11 [updated 2010 Jul 14].

16.

[74As]-Labeled monoclonal antibody against anionic phospholipids.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2008 Apr 14 [updated 2008 May 27].

17.

[11C]10-Methoxy-5-(2-propenyl)-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinoline.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2009 Jan 13 [updated 2009 Apr 6].

Supplemental Content

Support Center